Evaluation of the efficacy of an intraoperative laparoscopic transversus abdominis plane block under visual control using bupivacaine for elective laparoscopic bowel surgery
Not Applicable
- Conditions
- Colorectal neoplasmsInflammatory bowel diseasesDiverticulitis
- Registration Number
- DRKS00024839
- Lead Sponsor
- niversitätsmedizin Mannheim, Chirurgische Klinik
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
• >18 years
• ASA classes I-III
• all elective and laparoscopic operations with resection of the colon
• with or without ileostoma
Exclusion Criteria
• GFR < 30 ml/min
• BDI-V-Score > 35
• DASS-Score above the threshold value for depression, stress or fear
• allergy against bupivacaine or the used local anaesthetic
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amount of morphin equivalents used in the first 72h after surgery
- Secondary Outcome Measures
Name Time Method • average and max. NRS pain score in the first 72 hours after surgery (recorded every 12 hours)<br>• NRS pain score at arrival and departure from the recovery room<br>• duration of hospital stay<br>• side effects caused by tap block<br>• progression of the postoperative ileus and complications in the 30 days after the surgery, classified by Clavien-Dindo<br>• ERAS-compliance variables (clinical recovery)<br>• duration of surgery (first incision to last suture)<br>• duration of the tap block<br>• pin-prick test of the analgesia of the abdominal wall